3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Sponsor Class
INDUSTRY
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Breast
3
Conditions
Neoplasms
1905
Breast Neoplasms
1426
Carcinoma, Non-Small-Cell Lung
1179
Prostatic Neoplasms
740
Colorectal Neoplasms
686
Neoplasm Metastasis
624
Multiple Myeloma
548
Melanoma
529
Ovarian Neoplasms
456
Lung Neoplasms
447
Lymphoma, Non-Hodgkin
385
Recurrence
374
Lymphoma
374
Leukemia, Myeloid, Acute
370
Pancreatic Neoplasms
358
Carcinoma, Renal Cell
339
Carcinoma, Hepatocellular
286
Stomach Neoplasms
281
Leukemia, Lymphocytic, Chronic, B-Cell
268
Lymphoma, Follicular
254
Head and Neck Neoplasms
246
Glioblastoma
220
Leukemia
215
Small Cell Lung Carcinoma
183
Lymphoma, Large B-Cell, Diffuse
183
Squamous Cell Carcinoma of Head and Neck
181
Urinary Bladder Neoplasms
175
Carcinoma
175
Uterine Cervical Neoplasms
174
Advanced Solid Tumors
161
Interventions
exemestane
1
entinostat
1
Mammography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
INDUSTRY
×
Mammary Neoplasms, Animal
×
Clear all
NCT00676663
2022-05-11
ENCORE301
Syndax Pharmaceuticals
Phase 2
Completed
130 enrolled
18 charts
NCT02977247
2021-09-05
SV PCC ARM2
Delphinus Medical Technologies, Inc.
Completed
1,150 enrolled
NCT03257839
2021-09-05
SV PCC ARM1
Delphinus Medical Technologies, Inc.
Completed
7,409 enrolled